Xeriant, Inc.
XERI · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.16 | -0.30 | 0.00 |
| FCF Yield | -2.57% | -2.17% | -3.99% | -3.75% |
| EV / EBITDA | -28.14 | -74.27 | -36.94 | -56.30 |
| Quality | ||||
| ROIC | 7.21% | 22.68% | 48.68% | 48.76% |
| Gross Margin | 0.00% | 50.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | -0.08 | 0.53 | 0.69 | 0.95 |
| Growth | ||||
| Revenue 3-Year CAGR | 405,597.62% | 405,597.62% | -100.00% | -100.00% |
| Free Cash Flow Growth | -2.29% | 52.48% | 8.10% | -12.67% |
| Safety | ||||
| Net Debt / EBITDA | -5.44 | -36.44 | -16.74 | -23.76 |
| Interest Coverage | 6.79 | -4.25 | -6.43 | -4.37 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -2,698.29 | -16,798.97 | -5,825.66 |